Correction to: Hepatitis C virus infection in EU/EEA and United Kingdom prisons: Opportunities and challenges for action
BMC Public Health volume 23, Article number: 115 (2023)
Correction to: BMC Public Health20, 1670 (2020).
The original publication of this article contained a typo in the results section of the abstract. The incorrect and correct information is shown below. The original article has been updated.
Seroprevalence of HCV antibodies ranged from 2·3% to 82·6% while viraemic infections ranged from 5·7% to 8·2%, where reported.
Seroprevalence of HCV antibodies ranged from 2·3% to 82·8% while viraemic infections ranged from 5·7–82%, where reported.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s12889-020-09515-6.
About this article
Cite this article
Nakitanda, A.O., Montanari, L., Tavoschi, L. et al. Correction to: Hepatitis C virus infection in EU/EEA and United Kingdom prisons: Opportunities and challenges for action. BMC Public Health 23, 115 (2023). https://doi.org/10.1186/s12889-022-14317-z